リポソーム製品のグローバル市場2023-2027:癌、真菌感染症、疼痛管理、ウイルス用ワクチン、光線力学的療法

【英語タイトル】Global Liposomal Products Market 2023-2027

Technavioが出版した調査資料(IRTNTR71397-23)・商品コード:IRTNTR71397-23
・発行会社(調査会社):Technavio
・発行日:2023年2月2日
・ページ数:約120
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:北米、ヨーロッパ、アジア、その他地域
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥370,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

Technavio社の本調査レポートでは、世界のリポソーム製品市場規模が2023年から2027年の間に3,183.63百万ドルに到達すると見込んでおり、予測期間中の年平均成長率は9.65%になると予想しています。本レポートでは、リポソーム製品の世界市場について広く調査を行い、エグゼクティブサマリー、市場状況、市場規模予測、過去の市場規模、ファイブフォース分析、用途別(癌、真菌感染症、疼痛管理、ウイルス用ワクチン、光線力学的療法)分析、種類別(ブランド、ジェネリック)分析、顧客状況、地域別(北米、ヨーロッパ、アジア、アメリカ、ドイツ、中国、フランス、日本、その他地域)分析、企業分析など、以下の構成でまとめています。本レポートには、Acthera Therapeutics AG、Bausch Health Companies Inc.、Baxter International Inc.、Galen Ltd.、GENFIT SA、Gilead Sciences Inc.、Innocan Pharma Corp. Ltd.、Johnson and Johnson Services Inc.、Leadiant Biosciences Inc.、Lipella Pharmaceuticals Inc.、Liposoma B.V.などの企業情報が含まれています。
・エグゼクティブサマリー
・市場状況
・市場規模予測
・過去の市場規模
・ファイブフォース分析
・世界のリポソーム製品市場規模:用途別
- 癌における市場規模
- 真菌感染症における市場規模
- 疼痛管理における市場規模
- ウイルス用ワクチンにおける市場規模
- 光線力学的療法における市場規模
・世界のリポソーム製品市場規模:種類別
- ブランド製品の市場規模
- ジェネリック製品の市場規模
・顧客状況
・世界のリポソーム製品市場規模:地域別
- 北米のリポソーム製品市場規模
- ヨーロッパのリポソーム製品市場規模
- アジアのリポソーム製品市場規模
- アメリカのリポソーム製品市場規模
- ドイツのリポソーム製品市場規模
- 中国のリポソーム製品市場規模
- フランスのリポソーム製品市場規模
- 日本のリポソーム製品市場規模
- その他地域のリポソーム製品市場規模
・成長要因・課題・動向
・企業状況
・企業分析

Technavio社は、利益、価格、競争、プロモーションなどの主要なパラメーターを分析することにより、また複数のソースからのデータを調査、統合、および合計することにより、リポソーム製品市場の詳細な全体像を提示します。主要産業のインフルエンサーを特定することにより、さまざまな市場の側面を提示します。提示されたデータは包括的​​で信頼性が高く、一次および二次の広範な調査の結果です。 Technavio社の市場調査レポートは、正確なリポソーム製品市場の成長を予測するための定性的および定量的調査を使用し、完全な競争状況と詳細なベンダー選択方法と分析を提供します。

リポソーム製品の世界市場 2023-2027

Technavio社は、リポソーム製品市場をモニターしており、2022年から2027年にかけて3,183.63百万ドルの成長が予測され、予測期間中のCAGRは9.65%で加速すると予測しています。当レポートでは、リポソーム製品市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題に加え、約25のベンダーを網羅したベンダー分析を掲載しています。

当レポートでは、現在の市場シナリオ、最新動向と促進要因、市場全体の環境に関する最新分析を提供しています。真菌症の発生率の上昇、癌患者の有病率の増加、癌治療に伴う副作用などが市場を牽引しています。

Technavioのリポソーム製品市場は以下のように区分されます:

・用途別:
- がん
- 真菌感染症
- 疼痛管理
- ウイルスワクチン
- 光線力学療法

・タイプ別:
- ブランド
- ジェネリック

・地域別:
- 北米
- ヨーロッパ
- アジア
- その他の地域(ROW)

本調査では、今後数年間のリポソーム製品市場の成長を牽引する主な要因の一つとして、従来のプロセスよりもQBD(クオリティ・バイ・デザイン)の採用が増加していることを挙げています。また、戦略的提携の増加や、疎水性物質の循環時間を向上させるリポソーム製品の人気の高まりは、市場の大きな需要につながるでしょう。

Technavio社は、複数の情報源からのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。

リポソーム製品市場に関する弊社のレポートは以下の分野をカバーしています:
- リポソーム製品市場のサイジング
- リポソーム製品市場予測
- リポソーム製品市場の産業分析

Technavio社の確実なベンダー分析は、クライアントが市場でのポジションを向上できるように設計されており、これに沿って本レポートには、Acthera Therapeutics AG, Bausch Health Companies Inc., Baxter International Inc., Galen Ltd., GENFIT SA, Gilead Sciences Inc., Innocan Pharma Corp. Ltd., Johnson and Johnson Services Inc., Leadiant Biosciences Inc., Lipella Pharmaceuticals Inc., Liposoma B.V., Merrimack Pharmaceuticals Inc., Nanovex Biotechnologies SL, Pacira BioSciences Inc., Spectrum Pharmaceuticals Inc., Taiwan Liposome Co. Ltd., Takeda Pharmaceutical Co. Ltd., The Lubrizol Corp., Vascular Biosciences, and Viatris Incなどの企業情報が含まれています。また、リポソーム製品の市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートでは、主要ベンダーの分析に加え、包括的な市場およびベンダーの状況を掲載しています。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細な姿を提示します。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

❖ レポートの目次 ❖

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Type
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global liposomal products market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on Global liposomal products market 2017 – 2021 ($ million)
o 4.2 Application Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Application Segment 2017 – 2021 ($ million)
o 4.3 Type Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Type Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Application
o 6.1 Market segments
o Exhibit 30: Chart on Application – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Application – Market share 2022-2027 (%)
o 6.2 Comparison by Application
o Exhibit 32: Chart on Comparison by Application
o Exhibit 33: Data Table on Comparison by Application
o 6.3 Cancer – Market size and forecast 2022-2027
o Exhibit 34: Chart on Cancer – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Cancer – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Cancer – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Cancer – Year-over-year growth 2022-2027 (%)
o 6.4 Fungal infections – Market size and forecast 2022-2027
o Exhibit 38: Chart on Fungal infections – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Fungal infections – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Fungal infections – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Fungal infections – Year-over-year growth 2022-2027 (%)
o 6.5 Pain management – Market size and forecast 2022-2027
o Exhibit 42: Chart on Pain management – Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Pain management – Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Pain management – Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Pain management – Year-over-year growth 2022-2027 (%)
o 6.6 Viral vaccines – Market size and forecast 2022-2027
o Exhibit 46: Chart on Viral vaccines – Market size and forecast 2022-2027 ($ million)
o Exhibit 47: Data Table on Viral vaccines – Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Chart on Viral vaccines – Year-over-year growth 2022-2027 (%)
o Exhibit 49: Data Table on Viral vaccines – Year-over-year growth 2022-2027 (%)
o 6.7 Photodynamic therapy – Market size and forecast 2022-2027
o Exhibit 50: Chart on Photodynamic therapy – Market size and forecast 2022-2027 ($ million)
o Exhibit 51: Data Table on Photodynamic therapy – Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Chart on Photodynamic therapy – Year-over-year growth 2022-2027 (%)
o Exhibit 53: Data Table on Photodynamic therapy – Year-over-year growth 2022-2027 (%)
o 6.8 Market opportunity by Application
o Exhibit 54: Market opportunity by Application ($ million)
• 7 Market Segmentation by Type
o 7.1 Market segments
o Exhibit 55: Chart on Type – Market share 2022-2027 (%)
o Exhibit 56: Data Table on Type – Market share 2022-2027 (%)
o 7.2 Comparison by Type
o Exhibit 57: Chart on Comparison by Type
o Exhibit 58: Data Table on Comparison by Type
o 7.3 Branded – Market size and forecast 2022-2027
o Exhibit 59: Chart on Branded – Market size and forecast 2022-2027 ($ million)
o Exhibit 60: Data Table on Branded – Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Chart on Branded – Year-over-year growth 2022-2027 (%)
o Exhibit 62: Data Table on Branded – Year-over-year growth 2022-2027 (%)
o 7.4 Generic – Market size and forecast 2022-2027
o Exhibit 63: Chart on Generic – Market size and forecast 2022-2027 ($ million)
o Exhibit 64: Data Table on Generic – Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Chart on Generic – Year-over-year growth 2022-2027 (%)
o Exhibit 66: Data Table on Generic – Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Type
o Exhibit 67: Market opportunity by Type ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 69: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 70: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 71: Chart on Geographic comparison
o Exhibit 72: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 73: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 74: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 75: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 76: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 77: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 81: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 85: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 89: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 Germany – Market size and forecast 2022-2027
o Exhibit 93: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.9 China – Market size and forecast 2022-2027
o Exhibit 97: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 98: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 99: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 100: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.10 France – Market size and forecast 2022-2027
o Exhibit 101: Chart on France – Market size and forecast 2022-2027 ($ million)
o Exhibit 102: Data Table on France – Market size and forecast 2022-2027 ($ million)
o Exhibit 103: Chart on France – Year-over-year growth 2022-2027 (%)
o Exhibit 104: Data Table on France – Year-over-year growth 2022-2027 (%)
o 9.11 Japan – Market size and forecast 2022-2027
o Exhibit 105: Chart on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 106: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 107: Chart on Japan – Year-over-year growth 2022-2027 (%)
o Exhibit 108: Data Table on Japan – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 109: Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 110: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 111: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 112: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 113: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 114: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 115: Matrix on vendor position and classification
o 12.3 Acthera Therapeutics AG
o Exhibit 116: Acthera Therapeutics AG – Overview
o Exhibit 117: Acthera Therapeutics AG – Product / Service
o Exhibit 118: Acthera Therapeutics AG – Key offerings
o 12.4 Bausch Health Companies Inc.
o Exhibit 119: Bausch Health Companies Inc. – Overview
o Exhibit 120: Bausch Health Companies Inc. – Business segments
o Exhibit 121: Bausch Health Companies Inc. – Key news
o Exhibit 122: Bausch Health Companies Inc. – Key offerings
o Exhibit 123: Bausch Health Companies Inc. – Segment focus
o 12.5 Baxter International Inc.
o Exhibit 124: Baxter International Inc. – Overview
o Exhibit 125: Baxter International Inc. – Business segments
o Exhibit 126: Baxter International Inc. – Key news
o Exhibit 127: Baxter International Inc. – Key offerings
o Exhibit 128: Baxter International Inc. – Segment focus
o 12.6 Galen Ltd.
o Exhibit 129: Galen Ltd. – Overview
o Exhibit 130: Galen Ltd. – Product / Service
o Exhibit 131: Galen Ltd. – Key offerings
o 12.7 Gilead Sciences Inc.
o Exhibit 132: Gilead Sciences Inc. – Overview
o Exhibit 133: Gilead Sciences Inc. – Product / Service
o Exhibit 134: Gilead Sciences Inc. – Key news
o Exhibit 135: Gilead Sciences Inc. – Key offerings
o 12.8 Innocan Pharma Corp. Ltd.
o Exhibit 136: Innocan Pharma Corp. Ltd. – Overview
o Exhibit 137: Innocan Pharma Corp. Ltd. – Product / Service
o Exhibit 138: Innocan Pharma Corp. Ltd. – Key offerings
o 12.9 Johnson and Johnson Services Inc.
o Exhibit 139: Johnson and Johnson Services Inc. – Overview
o Exhibit 140: Johnson and Johnson Services Inc. – Business segments
o Exhibit 141: Johnson and Johnson Services Inc. – Key news
o Exhibit 142: Johnson and Johnson Services Inc. – Key offerings
o Exhibit 143: Johnson and Johnson Services Inc. – Segment focus
o 12.10 Leadiant Biosciences Inc.
o Exhibit 144: Leadiant Biosciences Inc. – Overview
o Exhibit 145: Leadiant Biosciences Inc. – Product / Service
o Exhibit 146: Leadiant Biosciences Inc. – Key offerings
o 12.11 Liposoma B.V.
o Exhibit 147: Liposoma B.V. – Overview
o Exhibit 148: Liposoma B.V. – Product / Service
o Exhibit 149: Liposoma B.V. – Key offerings
o 12.12 Merrimack Pharmaceuticals Inc.
o Exhibit 150: Merrimack Pharmaceuticals Inc. – Overview
o Exhibit 151: Merrimack Pharmaceuticals Inc. – Product / Service
o Exhibit 152: Merrimack Pharmaceuticals Inc. – Key offerings
o 12.13 Pacira BioSciences Inc.
o Exhibit 153: Pacira BioSciences Inc. – Overview
o Exhibit 154: Pacira BioSciences Inc. – Business segments
o Exhibit 155: Pacira BioSciences Inc. – Key offerings
o Exhibit 156: Pacira BioSciences Inc. – Segment focus
o 12.14 Spectrum Pharmaceuticals Inc.
o Exhibit 157: Spectrum Pharmaceuticals Inc. – Overview
o Exhibit 158: Spectrum Pharmaceuticals Inc. – Product / Service
o Exhibit 159: Spectrum Pharmaceuticals Inc. – Key offerings
o 12.15 Takeda Pharmaceutical Co. Ltd.
o Exhibit 160: Takeda Pharmaceutical Co. Ltd. – Overview
o Exhibit 161: Takeda Pharmaceutical Co. Ltd. – Product / Service
o Exhibit 162: Takeda Pharmaceutical Co. Ltd. – Key news
o Exhibit 163: Takeda Pharmaceutical Co. Ltd. – Key offerings
o 12.16 The Lubrizol Corp.
o Exhibit 164: The Lubrizol Corp. – Overview
o Exhibit 165: The Lubrizol Corp. – Product / Service
o Exhibit 166: The Lubrizol Corp. – Key offerings
o 12.17 Viatris Inc.
o Exhibit 167: Viatris Inc. – Overview
o Exhibit 168: Viatris Inc. – Business segments
o Exhibit 169: Viatris Inc. – Key offerings
o Exhibit 170: Viatris Inc. – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 171: Inclusions checklist
o Exhibit 172: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 173: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 174: Research methodology
o Exhibit 175: Validation techniques employed for market sizing
o Exhibit 176: Information sources
o 13.5 List of abbreviations
o Exhibit 177: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Application
Exhibits6: Executive Summary – Chart on Market Segmentation by Type
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global liposomal products market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Application Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Type Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Application – Market share 2022-2027 (%)
Exhibits31: Data Table on Application – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Application
Exhibits33: Data Table on Comparison by Application
Exhibits34: Chart on Cancer – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Cancer – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Cancer – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Cancer – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Fungal infections – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Fungal infections – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Fungal infections – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Fungal infections – Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Pain management – Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Pain management – Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Pain management – Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Pain management – Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Viral vaccines – Market size and forecast 2022-2027 ($ million)
Exhibits47: Data Table on Viral vaccines – Market size and forecast 2022-2027 ($ million)
Exhibits48: Chart on Viral vaccines – Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Viral vaccines – Year-over-year growth 2022-2027 (%)
Exhibits50: Chart on Photodynamic therapy – Market size and forecast 2022-2027 ($ million)
Exhibits51: Data Table on Photodynamic therapy – Market size and forecast 2022-2027 ($ million)
Exhibits52: Chart on Photodynamic therapy – Year-over-year growth 2022-2027 (%)
Exhibits53: Data Table on Photodynamic therapy – Year-over-year growth 2022-2027 (%)
Exhibits54: Market opportunity by Application ($ million)
Exhibits55: Chart on Type – Market share 2022-2027 (%)
Exhibits56: Data Table on Type – Market share 2022-2027 (%)
Exhibits57: Chart on Comparison by Type
Exhibits58: Data Table on Comparison by Type
Exhibits59: Chart on Branded – Market size and forecast 2022-2027 ($ million)
Exhibits60: Data Table on Branded – Market size and forecast 2022-2027 ($ million)
Exhibits61: Chart on Branded – Year-over-year growth 2022-2027 (%)
Exhibits62: Data Table on Branded – Year-over-year growth 2022-2027 (%)
Exhibits63: Chart on Generic – Market size and forecast 2022-2027 ($ million)
Exhibits64: Data Table on Generic – Market size and forecast 2022-2027 ($ million)
Exhibits65: Chart on Generic – Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on Generic – Year-over-year growth 2022-2027 (%)
Exhibits67: Market opportunity by Type ($ million)
Exhibits68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits69: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits70: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits71: Chart on Geographic comparison
Exhibits72: Data Table on Geographic comparison
Exhibits73: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits101: Chart on France – Market size and forecast 2022-2027 ($ million)
Exhibits102: Data Table on France – Market size and forecast 2022-2027 ($ million)
Exhibits103: Chart on France – Year-over-year growth 2022-2027 (%)
Exhibits104: Data Table on France – Year-over-year growth 2022-2027 (%)
Exhibits105: Chart on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits106: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits107: Chart on Japan – Year-over-year growth 2022-2027 (%)
Exhibits108: Data Table on Japan – Year-over-year growth 2022-2027 (%)
Exhibits109: Market opportunity By Geographical Landscape ($ million)
Exhibits110: Impact of drivers and challenges in 2022 and 2027
Exhibits111: Overview on Criticality of inputs and Factors of differentiation
Exhibits112: Overview on factors of disruption
Exhibits113: Impact of key risks on business
Exhibits114: Vendors covered
Exhibits115: Matrix on vendor position and classification
Exhibits116: Acthera Therapeutics AG – Overview
Exhibits117: Acthera Therapeutics AG – Product / Service
Exhibits118: Acthera Therapeutics AG – Key offerings
Exhibits119: Bausch Health Companies Inc. – Overview
Exhibits120: Bausch Health Companies Inc. – Business segments
Exhibits121: Bausch Health Companies Inc. – Key news
Exhibits122: Bausch Health Companies Inc. – Key offerings
Exhibits123: Bausch Health Companies Inc. – Segment focus
Exhibits124: Baxter International Inc. – Overview
Exhibits125: Baxter International Inc. – Business segments
Exhibits126: Baxter International Inc. – Key news
Exhibits127: Baxter International Inc. – Key offerings
Exhibits128: Baxter International Inc. – Segment focus
Exhibits129: Galen Ltd. – Overview
Exhibits130: Galen Ltd. – Product / Service
Exhibits131: Galen Ltd. – Key offerings
Exhibits132: Gilead Sciences Inc. – Overview
Exhibits133: Gilead Sciences Inc. – Product / Service
Exhibits134: Gilead Sciences Inc. – Key news
Exhibits135: Gilead Sciences Inc. – Key offerings
Exhibits136: Innocan Pharma Corp. Ltd. – Overview
Exhibits137: Innocan Pharma Corp. Ltd. – Product / Service
Exhibits138: Innocan Pharma Corp. Ltd. – Key offerings
Exhibits139: Johnson and Johnson Services Inc. – Overview
Exhibits140: Johnson and Johnson Services Inc. – Business segments
Exhibits141: Johnson and Johnson Services Inc. – Key news
Exhibits142: Johnson and Johnson Services Inc. – Key offerings
Exhibits143: Johnson and Johnson Services Inc. – Segment focus
Exhibits144: Leadiant Biosciences Inc. – Overview
Exhibits145: Leadiant Biosciences Inc. – Product / Service
Exhibits146: Leadiant Biosciences Inc. – Key offerings
Exhibits147: Liposoma B.V. – Overview
Exhibits148: Liposoma B.V. – Product / Service
Exhibits149: Liposoma B.V. – Key offerings
Exhibits150: Merrimack Pharmaceuticals Inc. – Overview
Exhibits151: Merrimack Pharmaceuticals Inc. – Product / Service
Exhibits152: Merrimack Pharmaceuticals Inc. – Key offerings
Exhibits153: Pacira BioSciences Inc. – Overview
Exhibits154: Pacira BioSciences Inc. – Business segments
Exhibits155: Pacira BioSciences Inc. – Key offerings
Exhibits156: Pacira BioSciences Inc. – Segment focus
Exhibits157: Spectrum Pharmaceuticals Inc. – Overview
Exhibits158: Spectrum Pharmaceuticals Inc. – Product / Service
Exhibits159: Spectrum Pharmaceuticals Inc. – Key offerings
Exhibits160: Takeda Pharmaceutical Co. Ltd. – Overview
Exhibits161: Takeda Pharmaceutical Co. Ltd. – Product / Service
Exhibits162: Takeda Pharmaceutical Co. Ltd. – Key news
Exhibits163: Takeda Pharmaceutical Co. Ltd. – Key offerings
Exhibits164: The Lubrizol Corp. – Overview
Exhibits165: The Lubrizol Corp. – Product / Service
Exhibits166: The Lubrizol Corp. – Key offerings
Exhibits167: Viatris Inc. – Overview
Exhibits168: Viatris Inc. – Business segments
Exhibits169: Viatris Inc. – Key offerings
Exhibits170: Viatris Inc. – Segment focus
Exhibits171: Inclusions checklist
Exhibits172: Exclusions checklist
Exhibits173: Currency conversion rates for US$
Exhibits174: Research methodology
Exhibits175: Validation techniques employed for market sizing
Exhibits176: Information sources
Exhibits177: List of abbreviations



★調査レポート[リポソーム製品のグローバル市場2023-2027:癌、真菌感染症、疼痛管理、ウイルス用ワクチン、光線力学的療法] (コード:IRTNTR71397-23)販売に関する免責事項を必ずご確認ください。
★調査レポート[リポソーム製品のグローバル市場2023-2027:癌、真菌感染症、疼痛管理、ウイルス用ワクチン、光線力学的療法]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆